Viatris Inc.: Hypertension, Pulmonary trials
The registry lists 12 Hypertension, Pulmonary studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 1Phase 2 2Phase 3 5Phase 4 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)CompletedNCT01801982Results posted
- A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The NewbornCompletedNCT01720524Phase 3Results posted
- Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial HypertensionCompletedNCT01642407Phase 4Results posted
- Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)TerminatedNCT01069861Phase 2Results posted
- To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 WeeksCompletedNCT00946114Results posted
- Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)CompletedNCT00666198Results posted
- Open Label Study of Sildenafil in Patients With Pulmonary Arterial HypertensionCompletedNCT00454207Phase 3Results posted
- The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAHCompletedNCT00159861Phase 3Results posted
- IV Sildenafil Persistent Pulmonary Hypertension Of The NewbornWithdrawnNCT01360671Phase 2
- Sildenafil IV Bolus StudyCompletedNCT00800592Phase 1
- A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00644605Phase 3
- Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionCompletedNCT00159887Phase 3